Inhibitors of hepatitis C virus
US-9296782-B2 · Mar 29, 2016 · US
US10335409B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10335409-B2 |
| Application number | US-201816005111-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 11, 2018 |
| Priority date | Jul 3, 2012 |
| Publication date | Jul 2, 2019 |
| Grant date | Jul 2, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Compounds of Formula I are disclosed As well as pharmaceutically acceptable salts thereof. Methods of using said compounds and pharmaceutical compositions containing said compounds are also disclosed.
Opening claim text (preview).
What is claimed is: 1. A compound of formula: 2. A compound of formula:
Related publications grouped by family.
Answers are generated from the same data shown on this page.